← Back to headlines
Gilead Sciences Acquires Ouro Medicines, Partners with Galapagos
Gilead Sciences has announced its acquisition of Ouro Medicines and a subsequent collaboration with Galapagos on the newly purchased assets, as reported by the Wall Street Journal.
23 Mar, 23:35 — 23 Mar, 23:35
Sources
Showing 1 of 1 sources
Related Stories
Book Explores the Concept of Extinction and Humanity's Impact
9m ago
Bosnian Scientist Dr. Suljo Ljukovac Wins Prestigious French Award
15m ago
ISRO Chief Reports Progress on India's Gaganyaan-I Mission
19m ago
The Spanish engineer who monitors the 'heart' of the Orion spacecraft from Houston: 'Four humans have visited a world different from ours, and that is something that affects us all'
27m ago